ClinConnect ClinConnect Logo
Search / Trial NCT06844162

Comparison of Postoperative Analgesic Efficacy of Suprainguinal Fascia Iliaca Block and Pericapsular Nerve Group Block With Lateral Femoral Cutaneous Nerve Block in Patients Undergoing Total Hip Arthroplasty

Launched by HACETTEPE UNIVERSITY · Feb 19, 2025

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

Suprainguinal Fascia Iliaca Block Peng Block Lateral Femoral Cutaneous Nerve Block Postoperative Analgesia

ClinConnect Summary

This clinical trial is studying different methods of pain relief after hip surgery, specifically total hip arthroplasty, which is a common procedure for patients with hip arthritis (also known as coxarthrosis). The researchers are comparing two types of pain relief techniques: the suprainguinal fascia iliaca block (SFIB) and the pericapsular nerve group block (PENG), alongside the lateral femoral cutaneous nerve block (LFCN). The goal is to see which method is more effective in reducing pain, decreasing the need for opioid medications, and helping patients regain movement and strength after surgery.

To participate in this study, individuals need to be scheduled for a total hip replacement due to hip arthritis and be between the ages of 65 and 74. However, some people may not be eligible if they have certain health issues, such as nerve problems, kidney or liver disease, bleeding disorders, allergies to anesthetics, prior surgeries on the same side of the body, or difficulties with mental understanding. Participants can expect to receive one of the pain relief methods during their surgery and will be monitored afterward to see how well they are managing pain and recovering. The study is currently recruiting participants and aims to improve pain management strategies for hip surgery patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients who are scheduled to undergo primary total hip arthroplasty with a diagnosis of coxarthosis
  • Exclusion Criteria:
  • Patients who have a history of neuropathy, patients with renal and hepatic insufficiency, patients with known coagulopathy, patients with a history of allergy to local anesthetics, patients with a history of inguinal surgery on the same side and patients with impaired mental status

About Hacettepe University

Hacettepe University is a leading research institution in Turkey, renowned for its commitment to advancing medical science and healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, the university supports a wide range of clinical trials aimed at improving patient outcomes and developing new therapeutic approaches. Hacettepe University is dedicated to maintaining the highest ethical standards and regulatory compliance in its research endeavors, fostering an environment that promotes scientific excellence and contributes to the global body of medical knowledge.

Locations

Ankara, , Turkey

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported